Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Allergen Research raises $17mm through Series A; advances peanut allergy immunotherapy

Executive Summary

Allergen Research Corp. (developing therapies to protect children with food allergies from accidental exposure) raised $17mm through its Series A round. Longitude Capital led the round, and joins Allergen’s board. The non-profit awareness group Food Allergy Research & Education (FARE), which helped found the company in 2011, also contributed.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies